EVALUATION OF MENTAL STATUS AND ITS CORRECTION AGOMELATINE IN PATIENTS WITH ACUTE CORONARY SYNDROME
https://doi.org/10.20538/1682-0363-2013-6-48-53
Abstract
Continuous sampling method using aquestionnaireHospitalAnxiety and Depression Scale (GSHTD) held survey 250 patients with acute coronary syndrome (ACS) admitted to the emergency Department of cardiologyInstituteofCardiology, SB of RAMS. Of these, 85 people (34%) were detected symptoms of anxiety and depression in 165 people (66%), anxiety and depressive symptoms were found. In a pilot randomized prospective comparative study included 46 people. Against the background of the basic treatment of ACS, 23 patients received an additional agomelatine. Results of the study are showed an improvement in mental status and quality of life
About the Authors
T. M. Poponina
Siberian State Medical University, Tomsk
Russian Federation
Poponina Tatiyana M.
Russian Federation
Poponina Tatiyana M.
K. I. Gunderina
Siberian State Medical University, Tomsk
Russian Federation
Gunderina Ksenia I.
Russian Federation
Gunderina Ksenia I.
Yu. S. Poponina
Siberian State Medical University, Tomsk;
Institute of Cardiology, Siberian Branch of the Russian Academy of Medical Sciences, Tomsk
Russian Federation
Poponina Yulia S.
Russian Federation
Poponina Yulia S.
V. A. Markov
Siberian State Medical University, Tomsk;
Institute of Cardiology, Siberian Branch of the Russian Academy of Medical Sciences, Tomsk
Russian Federation
Markov Valentin A.
Russian Federation
Markov Valentin A.
References
1. Brotman D.J., Golden S.H., Wittstein I.S. The cardiovascular toll of stress. Lancet, 2007, vol. 370, no. 9592, pp. 1089– 1100.
2. Rosengren A., Hawken S., Ounpuu S., Sliwa K., Zubaid M., Almahmeed W.A., Blackett K.N., Sitthi-amorn C., Sato H., Yusuf S. Interheart investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the Interheart study): case-control study. Lancet, 2004, Sep 11– 17, vol. 364, no. 9438, pp. 953–962.
3. Vasyuk Yu.A., Dovzhenko T.V. Diagnosis and treatment of depression in diseases of the cardiovascular system. Moscow, 2006. Р. 58 (in Russia).
4. Poponina T. M., Gunderina K.I., Poponina Yu.S., Simonova N.M., Markov V.A. Experience in the treatment of borderline mental disorders in patients with acute coronary syndrome. Siberian Med. J., 2011, vol. 26, no. 4 (2). pp. 208– 210 (in Russia).
5. Kornetov N.A, Lebedevа Ye.V. Depressive disorders in patients with myocardial infarction. Psychiatry and psychopharmacotherapy, 2003, vol. 5, no. 5. pp. 195–198 (in Russia).
6. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation, 1996, Jun. 1, vol. 93, no. 11, pp. 1976– 1980.
7. Frasure-Smith N., Lespérance F., Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation, 1995, Feb 15, vol. 91, no. 4. pp. 999–1005.
8. David Eric Kemp, Shishuka Malhotra, Kathleen N. Franco, Georg Tesar, David L. Bronson. Heart disease and depression: Don’t ignore the relationship. Cleveland Clinic. J. of Medicine, 2003, vol. 70, no. 9, pp. 745–761.
9. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamicpituitary-adrenal axis. Psychiatr Clin. North. Am., 1998, Jun. vol. 21, no. 2, pp. 293–307.
10. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh E.A., Castillo S, Peskind E.R. et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry, 1994, May, vol. 51, no. 5, pp. 411–422.
11. Allen M.T., Patterson S.M. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk. Biol. Psychol., 1995, Aug, vol. 41, no. 1, pp. 1–27.
12. Beck А.Т., Ward C.H., Mendelson M., Mock J., Erbaugh J. An Inventory for Measuring Depression. Archives of General Psychiatry, 1961, June, vol. 4, pp. 561–571.
13. Sheehan D.V., Sheehan K.H. The classification of phobic disorders. Int. J. Psychiatry Med. 1982–1983. Vol. 12, № 4. Р. 243–266.
14. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand., 1983, Jun., vol. 67, no. 6, pp. 361–370.
15. Nedoshivin A.O, Kutuzov A.E., Petrov N.N., Warsaw S.Yu., Perepech N.B. The study of quality of life and psychological status of patients with chronic heart failure. Heart Failure, 2000, vol. 1, no. 4, pp. 754 (in Russia).
16. Penninx B.W, Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., van Tilburg W. Depression and cardiac mortality: results from a ommunity-based longitudinal study. Arch Gen Psychiatry, 2001, Mar., vol. 58, no. 3, pp. 221–227.
Review
For citations:
Poponina T.M., Gunderina K.I., Poponina Yu.S., Markov V.A. EVALUATION OF MENTAL STATUS AND ITS CORRECTION AGOMELATINE IN PATIENTS WITH ACUTE CORONARY SYNDROME. Bulletin of Siberian Medicine. 2013;12(6):48-53. (In Russ.) https://doi.org/10.20538/1682-0363-2013-6-48-53
Views:
730
Email this article 